These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 27222549)

  • 21. Is remission of type 2 diabetes mellitus real?
    Stranks SN; Wittert GA
    Med J Aust; 2023 Nov; 219(10):448-450. PubMed ID: 37903479
    [No Abstract]   [Full Text] [Related]  

  • 22. Short-term incidence of protein-energy malnutrition is insufficient to evaluate long-term outcomes of hyposorptive bariatric surgery.
    Papadia FS; Adami GF; Camerini G
    Surg Endosc; 2024 Mar; 38(3):1117-1118. PubMed ID: 38286836
    [No Abstract]   [Full Text] [Related]  

  • 23. Comment on: Short-term outcomes of bariatric surgery in patients with inflammatory bowel disease: a national analysis.
    Batista Dantas AC
    Surg Obes Relat Dis; 2024 Feb; 20(2):152-153. PubMed ID: 38114386
    [No Abstract]   [Full Text] [Related]  

  • 24. Bariatric Surgery Produces Long-Term Benefits in Patients With Type 2 Diabetes: Evidence Supporting Its Expanded Use and Coverage.
    Wadden TA; Kushner RF; Chao AM
    JAMA; 2024 Feb; 331(8):643-645. PubMed ID: 38411656
    [No Abstract]   [Full Text] [Related]  

  • 25. Correction: The Importance of Glycaemic Control Before Bariatric Surgery: Preventing Microvascular and Metabolic Complications.
    Sankar A; Mudaliar RN; Kochhar RS; Summers LKM; Syed AA; Majeed W
    Obes Surg; 2024 Jun; 34(6):2250. PubMed ID: 38431765
    [No Abstract]   [Full Text] [Related]  

  • 26. Bariatric/Metabolic Surgery to Treat Type 2 Diabetes in Patients With a BMI <35 kg/m2.
    Cummings DE; Cohen RV
    Diabetes Care; 2016 Jun; 39(6):924-33. PubMed ID: 27222550
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Identifying Barriers to Appropriate Use of Metabolic/Bariatric Surgery for Type 2 Diabetes Treatment: Policy Lab Results.
    Rubin JK; Hinrichs-Krapels S; Hesketh R; Martin A; Herman WH; Rubino F
    Diabetes Care; 2016 Jun; 39(6):954-63. PubMed ID: 27222554
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Long-term Microvascular Disease Outcomes in Patients With Type 2 Diabetes After Bariatric Surgery: Evidence for the Legacy Effect of Surgery.
    Coleman KJ; Haneuse S; Johnson E; Bogart A; Fisher D; O'Connor PJ; Sherwood NE; Sidney S; Theis MK; Anau J; Schroeder EB; O'Brien R; Arterburn D
    Diabetes Care; 2016 Aug; 39(8):1400-7. PubMed ID: 27271192
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Erratum. A Randomized Controlled Trial of Cognitive Behavioral Therapy for Adherence and Depression (CBT-AD) in Patients With Uncontrolled Type 2 Diabetes. Diabetes Care 2014;37:625-633.
    Safren SA; Gonzalez JS; Wexler DJ; Psaros C; Delahanty LM; Blashill AJ; Margolina AI; Cagliero E
    Diabetes Care; 2016 Jun; 39(6):1065. PubMed ID: 27222555
    [No Abstract]   [Full Text] [Related]  

  • 30. Bariatric Surgery versus Intensive Medical Therapy for Diabetes - 5-Year Outcomes.
    Schauer PR; Bhatt DL; Kirwan JP; Wolski K; Aminian A; Brethauer SA; Navaneethan SD; Singh RP; Pothier CE; Nissen SE; Kashyap SR;
    N Engl J Med; 2017 Feb; 376(7):641-651. PubMed ID: 28199805
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The Long-Term Effects of Bariatric Surgery on Type 2 Diabetes Remission, Microvascular and Macrovascular Complications, and Mortality: a Systematic Review and Meta-Analysis.
    Sheng B; Truong K; Spitler H; Zhang L; Tong X; Chen L
    Obes Surg; 2017 Oct; 27(10):2724-2732. PubMed ID: 28801703
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Bariatric Surgery as a Long-Term Treatment for Type 2 Diabetes/Metabolic Syndrome.
    Hanipah ZN; Schauer PR
    Annu Rev Med; 2020 Jan; 71():1-15. PubMed ID: 31986081
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Long-term outcomes of macrovascular diseases and metabolic indicators of bariatric surgery for severe obesity type 2 diabetes patients with a meta-analysis.
    Yan G; Wang J; Zhang J; Gao K; Zhao Q; Xu X
    PLoS One; 2019; 14(12):e0224828. PubMed ID: 31794559
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The Effects of Bariatric Surgery on Islet Function, Insulin Secretion, and Glucose Control.
    Douros JD; Tong J; D'Alessio DA
    Endocr Rev; 2019 Oct; 40(5):1394-1423. PubMed ID: 31241742
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Gut adaptation after metabolic surgery and its influences on the brain, liver and cancer.
    Sinclair P; Brennan DJ; le Roux CW
    Nat Rev Gastroenterol Hepatol; 2018 Oct; 15(10):606-624. PubMed ID: 30181611
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Targeting the Incretin/Glucagon System With Triagonists to Treat Diabetes.
    Capozzi ME; DiMarchi RD; Tschöp MH; Finan B; Campbell JE
    Endocr Rev; 2018 Oct; 39(5):719-738. PubMed ID: 29905825
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Glucagon-like peptide 1 in health and disease.
    Andersen A; Lund A; Knop FK; Vilsbøll T
    Nat Rev Endocrinol; 2018 Jul; 14(7):390-403. PubMed ID: 29728598
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Food Intake and Eating Behavior After Bariatric Surgery.
    Al-Najim W; Docherty NG; le Roux CW
    Physiol Rev; 2018 Jul; 98(3):1113-1141. PubMed ID: 29717927
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Signalling from the periphery to the brain that regulates energy homeostasis.
    Kim KS; Seeley RJ; Sandoval DA
    Nat Rev Neurosci; 2018 Apr; 19(4):185-196. PubMed ID: 29467468
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Metabolic surgery for the treatment of type 2 diabetes in obese individuals.
    Cummings DE; Rubino F
    Diabetologia; 2018 Feb; 61(2):257-264. PubMed ID: 29224190
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.